Table 1 The basic information

Demographics

 Sex (male/female)

66/43

 Age, y

65 (45, 76.5)

 HbA1c, %

5.9 (5.2, 6.85)

 FBG, mmol/L

7.67 (6.11, 10.24)

Intestinal barrier biomarkers

 DAO, U/L

24.1 (10.11, 37.1)

 D-lactate, mg/L

35.83 (19.25, 52.72)

 LPS, U/L

10.31 (6.28, 18.85)

Infection and immunity

 WBC, 10^9/L

15.14 ± 7.72

 NEU proportion, %

91.1 (88.0, 93.9)

 CRP, mg/L

70.1 (16.75, 172.8)

 Procalcitonin, µg/L

2.05 (0.66, 9.32)

 HLA-DR, %

45.45 (30.43, 63.65)

 Temperature, ℃

38.2 (37.45, 38.75)

Respiratory and circulatory system

 Oxygenation index

260 (197, 340)

 Respiratory rate, RPM

23 (19.5, 25)

 Heart rate, RPM

108 (88, 122)

 MAP, mmHg

66.67 (60.67, 81.33)

 Artery blood pH

7.36 (7.27, 7.41)

 Lactate, mmol/L

3.2 (1.8, 5.1)

 Dosage of NE, ug/kg/min

0.13 (0, 0.43)

Renal function

 Urea nitrogen, mmol/L

8.2 (5.35, 11.5)

 Creatinine, µmol/L

105.8 (72.25, 166.9)

 AKI morbidity (N)

35.8% (39)

Liver function

 ALT, U/L

38 (18.5, 87)

 AST, U/L

45 (27.5, 92)

 Total bilirubin, µmol/L

20.4 (12.95, 32.05)

 Direct bilirubin, µmol/L

10.2 (6.3, 17.45)

 Total protein, g/L

51.42 ± 12.96

 Albumin, g/L

28.01 ± 7.91

 Prealbumin, mg/L

148.76 ± 82.48

Disease severity and prognosis

 APACHE II

16 (11, 21)

 SOFA

7 (6, 9.5)

 LOS in hospital, day

22 (12, 40.5)

 LOS in ICU, day

6 (3, 14)

 90-day mortality (N)

17.6% (19)